Evidence map›Paper›PMID 41355991›Full record

ArticleFrontiers in cellular and infection microbiology2025

Increased abundance of actinobacteria and upregulation of primary bile acid biosynthesis in diabetic foot ulcers.

Mi Zhou, Han Zhang, Rui Zhang, Tianshu Wei, Xiaojun Zhou

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Foods (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mi Zhou *Department of Vascular Surgery, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Han Zhang *Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Institute of Nephrology, Jinan, Shandong, China.
Rui ZhangPhase I Drug Clinical Trial Center, Qilu Hospital of Shandong University, Jinan, China.
Tianshu WeiClinical Laboratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.
Xiaojun ZhouDepartment of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Institute of Nephrology, Jinan, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Vascular microbial imbalance may disrupt homeostasis and impair wound healing by triggering local and systemic inflammation. Diabetic foot (DF), a severe complication of diabetes, is frequently associated with bacterial infections. However, the arterial microbiota in DF remains unexplored. This study characterizes the arterial microbiota in DF patients and investigates its potential role in disease progression. Methods: A total of 22 patients were recruited, including those undergoing surgery for DF, patients with lower limb atherosclerosis (AS) requiring surgery, and trauma patients who underwent amputation as healthy controls (C). Samples were obtained under sterile conditions, and 16S rRNA sequencing was performed. Microbial diversity and functional pathways were analyzed using QIIME2. Results: Alpha diversity analysis revealed a progressive decline in microbial diversity from the C group to the AS and DF groups. Beta diversity analysis demonstrated that the DF and AS groups clustered closely, while both exhibited significant microbial compositional differences compared to the C group (ANOSIM, Conclusion: DF is associated with distinct alterations in arterial microbiota composition and metabolic pathways. Alterations in Actinobacteria and primary bile acid biosynthesis may be relevant to DF progression and could serve as potential therapeutic targets.

Indexed as

ActinobacteriaBile Acids and SaltsDiabetic FootAgedAtherosclerosisDNA, BacterialFemaleHumansMaleMicrobiotaMiddle AgedRNA, Ribosomal, 16SUp-RegulationBile Acids and SaltsDNA, BacterialRNA, Ribosomal, 16S16S rRNA sequencingactinobacteriaatherosclerosisdiabetic footmicrobiotaprimary bile acid biosynthesis

Identifiers

PMID41355991
PMCPMC12675428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.